Advanced Cell & Gene Therapy CDMO Solutions

Our Capabilities

Bringing Your Cell Therapy Products to the Market

RoslinCT helps therapy developers turn complex cell therapy processes into phase-appropriate, cGMP-ready programs across immunotherapies, gene-edited therapies, and stem cell/iPSC platforms.

We support both autologous and allogeneic manufacturing through flexible suite design, closed processing, chain-of-identity controls, and tailored release testing for clinical and commercial programs.

RoslinCT--ipscs--process-developement-scientist

cGMP iPSC Development

Pioneers in cGMP iPSCs

Explore More

Process & Analytical Development

Begin with the end in mind

Explore more

cGMP Cell Banking

Accelerate your Cell Bank Production

Explore More

RoslinCT-female-scientist-in-tech-transfer-lab

Manufacturing Science & Technology

A comprehensive approach to technology transfer

Explore More

Clinical & Commercial Manufacturing

Delivering innovative, life-changing cell therapies

Explore More

RoslinCT-quality-control-scientist-in-lab

Quality & Regulatory Compliance

A holistic innovative approach to quality

Explore More

Supply Chain & Logistics

Managing logistics with patients in mind

Explore More

Success Powered by Cutting-Edge Science

RoslinCT, as one of the first in the world to produce clinical-grade human pluripotent stem cells, has a strong focus on science and innovation. In collaboration with Vertex Pharmaceuticals, RoslinCT developed, from early process development through commercialization, the First CRISPR-Edited Cell Therapy Product, exa-cel for the treatment of sickle cell disease and transfusion-dependent beta thalassemia.

Let’s Partner Up

500 +

cGMP Batches Produced

for various indications

22 +

cGMP Suites

allowing simultaneous processing

500 +

Experienced Employees

across two continents

20 +

Cell Types

experience supporting auto and allo processes

Purpose-Built cGMP Manufacturing Facilities

Benefit from our world-class, innovative cell therapy development and cGMP manufacturing facilities

RoslinCT-cell-therapy-facility-operations-command-center

Partner with Us

About RoslinCT

Get to Know the Team and What We Stand for

Innovative Solutions. Trusted Partnerships. Life-changing Treatments.

Following the world-breaking first cloning of a mammal (Dolly the Sheep) at the Roslin Institute within the University of Edinburgh (UK) in 1997, there was worldwide interest to access Roslin’s technology and expertise. RoslinCT was established in 2006 to translate this cutting-edge science and apply it to the development of human medicines.

To save the lives of patients by empowering our partners to efficiently progress cell & gene therapies from development to commercialization, as their advanced CDMO partner of choice.

We are a team of passionate professionals with decades of experience in the advanced cell & gene therapy industry.

The Scientific Advisory Board is comprised of cell and gene therapy pioneers with extensive domain experience.

Deep Scientific Expertise and Diversity of Cell Platform Experience
One of the First in the World to Produce Clinical-Grade Human Pluripotent Cells
Advanced Program Utilizing Vertex Pharmaceutical’s CRISPR-Edited Stem Cell-Based Therapy
Process and Analytical Development Laboratory
Clinical and Commercial Manufacturing Capacity
Integration of Best-in-Class Cell Therapy Software Solutions
Extensive Training
Adaptive Approach to Partner Relationships